PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
20-May-2020 Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer AstraZeneca
18-May-2020 New date announced for SMi’s Pharma Microbiology East Coast Conference SMi Group
12-May-2020 COVID-19: Werum offers live Consultation Hours for pharma and biotech companies Werum IT Solutions
11-May-2020 Rescheduled CPhI South East Asia to now take place in November CPhI SEA
11-May-2020 CPhI & P-MEC China to host ‘Virtual Expo Connect’ in June CPhI China
07-May-2020 Scientists bring together world’s coronavirus research in 'intelligent' online database The Institute of Cancer Research
07-May-2020 Sosei Heptares announces further scientific progress with orexin agonist program in conjunction with spin-off companies Orexia and Inexia Sosei Heptares
07-May-2020 Rothamsted Research answers White House call for coronavirus data help Rothamsted Research
07-May-2020 PTC Therapeutics to Acquire Censa Pharmaceuticals PTC Therapeutics
07-May-2020 MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements MediPharm Labs
06-May-2020 Santhera Signs Agreements in Gene Therapy Research for Congenital Muscular Dystrophy with Rutgers University Santhera Pharmaceuticals
06-May-2020 Trio of Awards for Synergy Vision in Just One (Four-Day-Working) Week … prestigious Platinum from Investors in People, UK’s 3rd Best Small Workplace for 2020 by Great Place to Work® and platinum and gold Muse Creative Awards … Synergy Vision (SV)
05-May-2020 Independent expert review of data supports the potential of XF-73 to address antimicrobial resistance Destiny Pharma
05-May-2020 Vifor Pharma announces Akebia’s Positive top-line results from global phase-III program of vadadustat for treatment of anaemia due to Chronic Kidney Disease in adult dialysis-dependent patients Vifor Pharma
01-May-2020 Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) for Children and Adolescents With Cystic Fibrosis Between the Ages 6 Months and 18 Years With the R117H Mutation in the CFTR Gene Vertex Pharmaceuticals
30-Apr-2020 New dates announced for Smart Water Systems 2020 SMi Group Ltd
29-Apr-2020 BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany BioNTech SE
29-Apr-2020 SANGAMO THERAPEUTICS ANNOUNCES PRESENTATIONS AT 2020 ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY SANGAMO THERAPEUTICS
29-Apr-2020 Audited results for the year ended 31 December 2019 and clinical development update Destiny Pharma plc
29-Apr-2020 Bone Therapeutics secures EUR 11.0 million financing Bone Therapeutics